Adjuvant Therapy for Resected Biliary Tract Cancer (beta)
Based on guidelines from the American Society of Clinical Oncology.
Strength
Strong recommendation
Moderate recommendation
Weak recommendation
N/A
Evidence
High quality evidence
Intermediate quality evidence
Low quality evidence
Insufficient evidence
N/A